Research with real-world impact, efforts to build the capacity of Australia’s small businesses and breakthroughs in technology development have been recognised with Awards for Excellence at the DMTC Annual Conference for 2024.
Awardees were honoured in seven categories, with each demonstrating commitment to excellence and collaboration across a diverse portfolio of programs and projects.
The CEO of Australian biotech company Sementis Limited, Dr Anne Collins, has been honoured with the Collaboration Award at the DMTC Annual Conference for 2024.
Often described as the MVP Award, the Collaboration Award honours a leader who embodies the spirit of collaboration that is integral to DMTC’s strategic intent and outlook.
Australia’s defence industry is grappling with the rapid evolution of technology. But despite the challenges posed, opportunities abound for companies, big and small, to enhance their international competitiveness, efficiency and workforce outcomes. One of a number of ways DMTC is bolstering Australia’s sovereign industrial base is by equipping Australian small and medium-sized enterprises (SME) to leverage Industry 4.0 technologies. DMTC’s Education program reinforces this objective by exposing undergraduate engineering, computer science and software development students to work experience supporting these SMEs as they seek to digitise their manufacturing operations.
DMTC is a not-for-profit company that designs, manages and leads multi-party R&D initiatives that deliver enhanced defence, national security and health security capabilities, and strengthen Australia’s industrial capacity.
